» Articles » PMID: 10164058

Rational Prescribing of Antibacterials in Ambulatory Children

Overview
Specialty Pharmacology
Date 1996 Nov 3
PMID 10164058
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The rational prescribing of oral antimicrobial agents for bacterial infections in children who can be treated in an ambulatory setting is the subject of this review. First, restrictive use of antibacterials is advocated to avoid widespread development of bacterial resistance. The use of simple methods, suitable for office use, to discern viral from bacterial infections is recommended. Second, in selecting an antimicrobial agent, the physician should consider a number of distinctive features of each agent. Besides aspects of pharmacokinetics, antibacterial spectrum and tolerability, the number of daily doses and, of particular importance for children, the palatability of suspensions plays an important role in achieving patient compliance. Agents that can be administered once or twice daily and possess an agreeable taste in addition to proven efficacy, established tolerability and a reasonable price are to be preferred. Specific paediatric aspects in choosing among penicillins, cephalosporins, macrolides and other oral antibacterials are discussed. For pharmacoeconomic reasons, the optimal duration of antibacterial treatment and the role of short course therapy for various bacterial infections should be studied in more detail. Finally, rational antimicrobial treatment of common paediatric bacterial infections, such as streptococcal tonsillopharyngitis, acute otitis media, acute sinusitis, bacterial pneumonia, pertussis, Lyme borreliosis (early stage) and lower urinary tract infection is reviewed.

Citing Articles

Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.

Marques I, Calvi I, Cruz S, M F Sanchez L, Baroni I, Oommen C Eur J Pediatr. 2022; 181(11):3795-3804.

PMID: 36066660 DOI: 10.1007/s00431-022-04603-8.


Examining a New Scale for Evaluating Taste in Children (TASTY).

Wagner J, Pabon G, Terrill D, Abdel-Rahman S J Pediatr Pharmacol Ther. 2020; 25(2):131-138.

PMID: 32071588 PMC: 7025747. DOI: 10.5863/1551-6776-25.2.131.


Optimizing oral medications for children.

Mennella J, Beauchamp G Clin Ther. 2008; 30(11):2120-32.

PMID: 19108800 PMC: 2744307. DOI: 10.1016/j.clinthera.2008.11.018.


Stability, dose uniformity, and palatability of three counterterrorism drugs-human subject and electronic tongue studies.

Sadrieh N, Brower J, Yu L, Doub W, Straughn A, Machado S Pharm Res. 2005; 22(10):1747-56.

PMID: 16180133 DOI: 10.1007/s11095-005-6387-x.

References
1.
Wise R . Oral cephalosporins. J Antimicrob Chemother. 1992; 29(2):91-2. DOI: 10.1093/jac/29.2.91. View

2.
Shope J . Medication compliance. Pediatr Clin North Am. 1981; 28(1):5-21. DOI: 10.1016/s0031-3955(16)33959-1. View

3.
CHAMBERLAIN J, Boenning D, Waisman Y, Ochsenschlager D, Klein B . Single-dose ceftriaxone versus 10 days of cefaclor for otitis media. Clin Pediatr (Phila). 1994; 33(11):642-6. DOI: 10.1177/000992289403301101. View

4.
Berman S . Otitis media in children. N Engl J Med. 1995; 332(23):1560-5. DOI: 10.1056/NEJM199506083322307. View

5.
Brogden R, Carmine A, Heel R, Speight T, Avery G . Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections. Drugs. 1982; 23(6):405-30. DOI: 10.2165/00003495-198223060-00001. View